在细胞氧化应激和死亡中无与伦比的上腺素受体信号传递
Lilly Underwood1, Chun-Sun Jiang1, Joo-Yeun Oh1
1Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL.
Current opinion in physiology
|July 29, 2024
概括
甲基荷胺 (CA) 激活上腺素受体 (AR),影响心脏功能. 通过ARs了解CA毒性对于开发新的心力衰竭治疗方法至关重要.
科学领域:
- 心血管生理学心血管生理学
- 分子心脏病学分子心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- катехоламин (CA) 对于心脏适应至关重要,但长时间的高水平会导致心血管损伤,导致心力衰竭 (HF).
- 上腺素受体 (ARs) 调解关键的内和长效应,但它们在CA诱导的毒性和细胞死亡中的作用越来越被认可.
- 了解α1-AR (α1AR) 和β-AR (βAR) 在心脏重塑和存活中的特定作用至关重要.
研究的目的:
- 为了阐明ARs在catecholamine毒性的背景下复杂的信号通路.
- 突出α1AR和βAR在心脏重塑和细胞生存机制中的参与.
- 确定阻碍心血管疾病新疗法发展的知识差距.
主要方法:
- 关于心血管系统中甲基胺信号传递和上腺素受体功能的当前文献的综述.
- 对研究AR亚型对心脏重塑,氧化应激和细胞死亡的贡献进行分析.
- 关于AR信号传递和细胞生存途径之间的相互作用信息的综合.
主要成果:
- AR信号传递是复杂的,有不同的亚型介导着对心脏的不同影响.
- 通过AR激活的长时间CA暴露会导致氧化应激和细胞功能障碍.
- α1AR和βAR在心脏重塑和细胞死亡途径中的特定作用至关重要,但尚未完全理解.
结论:
- 对AR信号复杂性的更深入的理解对于解决甲醇胺诱导的心血管损伤至关重要.
- 针对特定的AR途径可能为心力衰竭提供潜在的治疗途径.
- 需要进一步的研究来弥合有关AR,氧化应激和心血管疾病中的细胞死亡的知识差距.
关键词:
上腺体受体的受体灭症 (apoptosis) 是一种死亡的过程.类甲基胺 (Catecholamines) 是一种类甲基胺.心灵的心灵心灵的心灵心灵的心灵线粒体中的线粒体.氧化应激是一种氧化应激.更多相关视频
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
8.1K
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
8.6K
相关概念视频
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
01:30Overview of Cell Death
7.1K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K
01:27Adrenergic Receptors (Adrenoceptors): Classification
2.4K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.4K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
01:26Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
01:31Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K